Skip to content
healthcare.dev

Novolin 70/30

NDC 0169-1837, Human Insulin, injection, suspension, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-1837
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Product type
HUMAN OTC DRUG
Marketing category
BLA
Application
BLA019991
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1837 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN HUMAN100 [iU]/mL

Pharmacologic classes

Insulin [CS]; Insulin [EPC]

Package NDCNDC-11Package
0169-1837-02001691837021 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIAL
0169-1837-11001691837111 VIAL in 1 CARTON (0169-1837-11) / 10 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 00169183711

    GET /v1/drugs/nadac/00169183711

Use it

Look up 0169-1837 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-1837 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-1837. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.